178 related articles for article (PubMed ID: 22520080)
1. [Recommendations against prostate cancer screening with PSA].
Marzo-Castillejo M; Nuin-Villanueva MÁ; Vela-Vallespín C
Aten Primaria; 2012 Jul; 44(7):377-8. PubMed ID: 22520080
[No Abstract] [Full Text] [Related]
2. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
[No Abstract] [Full Text] [Related]
3. Screening for prostate cancer.
Croswell J; Shin YR
Am Fam Physician; 2013 Feb; 87(4):283-4. PubMed ID: 23418805
[No Abstract] [Full Text] [Related]
4. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
Borofsky MS; Makarov DV
Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
[No Abstract] [Full Text] [Related]
5. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: Prudent practice optimizes screening outcomes.
Auvinen A
Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
[No Abstract] [Full Text] [Related]
7. Prostate-specific antigen screening, why have the guidelines changed?
Sountoulides P; Moutzouris G
Expert Rev Anticancer Ther; 2014 Nov; 14(11):1277-81. PubMed ID: 25306859
[TBL] [Abstract][Full Text] [Related]
8. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
Crawford ED; Rosenberg MT; Partin AW; Cooperberg MR; Maccini M; Loeb S; Pettaway CA; Shore ND; Arangua P; Hoenemeyer J; Leveridge M; Leapman M; Pinto P; Thompson IM; Carroll P; Eastham J; Gomella L; Klein EA
Urology; 2016 Oct; 96():116-120. PubMed ID: 27450937
[No Abstract] [Full Text] [Related]
9. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction.
Carroll PR
JAMA Surg; 2018 Aug; 153(8):701-702. PubMed ID: 29801146
[No Abstract] [Full Text] [Related]
10. Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.
Rahbar H; Karabon P; Menon M; Trinh QD; Abdollah F
Eur Urol Focus; 2018 Dec; 4(6):1002-1004. PubMed ID: 28753856
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: PSA update--no change yet.
Phillips R
Nat Rev Urol; 2014 Sep; 11(9):483. PubMed ID: 25134834
[No Abstract] [Full Text] [Related]
12. Re: optimization of PSA screening policies: a comparison of the patient and societal perspectives.
Penson DF
J Urol; 2013 Feb; 189(2):529-30. PubMed ID: 23312159
[No Abstract] [Full Text] [Related]
13. Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.
Pini G; Collins J; Ghadjar P; Wiklund P
Curr Urol Rep; 2015 May; 16(5):28. PubMed ID: 25773347
[TBL] [Abstract][Full Text] [Related]
14. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
[TBL] [Abstract][Full Text] [Related]
15. Reevaluating PSA Testing Rates in the PLCO Trial.
Shoag JE; Mittal S; Hu JC
N Engl J Med; 2016 May; 374(18):1795-6. PubMed ID: 27144870
[No Abstract] [Full Text] [Related]
16. The effect of lowering the prostate-specific antigen normal cutoff on referral rates to urology.
Shenker BS; Stern J
J Am Board Fam Med; 2012; 25(6):927-9. PubMed ID: 23136335
[TBL] [Abstract][Full Text] [Related]
17. PSA screening: the USPSTF got it wrong.
Scherger JE
J Fam Pract; 2013 Nov; 62(11):616, 618. PubMed ID: 24288701
[No Abstract] [Full Text] [Related]
18. PSA testing and early management of test-detected prostate cancer--consensus at last.
Lawrentschuk N
BJU Int; 2016 Apr; 117 Suppl 4():5-6. PubMed ID: 27094969
[No Abstract] [Full Text] [Related]
19. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
Nazim SM; Raza SJ; Ather MH
J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
[No Abstract] [Full Text] [Related]
20. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
Black A; Berg CD
Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
